electroCore, Inc. (NASDAQ:ECOR – Get Free Report) CFO Joshua Lev sold 6,667 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $9.00, for a total transaction of $60,003.00. Following the transaction, the chief financial officer directly owned 84,889 shares of the company’s stock, valued at $764,001. This represents a 7.28% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.
electroCore Stock Performance
ECOR stock opened at $9.76 on Monday. The firm has a 50 day moving average price of $6.60 and a 200-day moving average price of $6.09. electroCore, Inc. has a 52-week low of $4.16 and a 52-week high of $10.27. The firm has a market capitalization of $81.01 million, a price-to-earnings ratio of -5.51 and a beta of 0.83.
electroCore (NASDAQ:ECOR – Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The company reported ($0.59) earnings per share for the quarter, hitting the consensus estimate of ($0.59). The company had revenue of $9.58 million for the quarter, compared to the consensus estimate of $9.01 million. electroCore had a negative return on equity of 1,956.38% and a negative net margin of 44.08%. As a group, sell-side analysts forecast that electroCore, Inc. will post -1.48 earnings per share for the current fiscal year.
Institutional Trading of electroCore
Wall Street Analysts Forecast Growth
ECOR has been the subject of several analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of electroCore in a report on Friday, March 27th. upgraded shares of electroCore to a “strong-buy” rating in a research note on Tuesday, February 3rd. Finally, Zacks Research upgraded shares of electroCore from a “strong sell” rating to a “hold” rating in a research note on Friday, March 27th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $18.00.
Check Out Our Latest Research Report on electroCore
electroCore Company Profile
electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.
The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.
Read More
- Five stocks we like better than electroCore
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
- 3 Dividend Kings That Earn Their Crown Every Quarter
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.
